KEGG   DRUG: Metformin hydrochloride and sitagliptin phosphate
Entry
D10261            Mixture   Drug                                   
Name
Metformin hydrochloride and sitagliptin phosphate;
Janumet (TN)
Product
Component
Metformin hydrochloride [DR:D00944], (Sitagliptin phosphate hydrate [DR:D06645] | Sitagliptin [DR:D08516] | Sitagliptin phosphate [DR:D12294])
Class
Antidiabetic agent
 DG02044  Hypoglycemic agent
  DG03032  Combination of metformin and DPP-4 inhibitor
Remark
ATC code: A10BD07
Product: D10261<US>
Efficacy
Antidiabetic
  Disease
Type 2 diabetes mellitus [DS:H00409]
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 A ALIMENTARY TRACT AND METABOLISM
  A10 DRUGS USED IN DIABETES
   A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
    A10BD Combinations of oral blood glucose lowering drugs
     A10BD07 Metformin and sitagliptin
      D10261  Metformin hydrochloride and sitagliptin phosphate <US>
USP drug classification [BR:br08302]
 Blood Glucose Regulators
  Antidiabetic Combinations
   Metformin Hydrochloride/ Sitagliptin
    D10261  Metformin hydrochloride and sitagliptin phosphate
Drug groups [BR:br08330]
 Antidiabetic agent
  DG02044  Hypoglycemic agent
   DG03032  Combination of metformin and DPP-4 inhibitor
    D10261  Metformin hydrochloride and sitagliptin phosphate
Drug classes [BR:br08332]
 Antidiabetic agent
  DG02044  Hypoglycemic agent
   D10261  Metformin hydrochloride and sitagliptin phosphate
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10261
Other DBs
PubChem: 163312292

» Japanese version   » Back

DBGET integrated database retrieval system